Sex differences in thyroid dysfunction onset timing induced by immune checkpoint inhibitors: JADER disproportionality analysis
ICI-TD occurs earlier in female patients. This finding highlights the need for sex-specific monitoring to optimize early detection and management of thyroid-related adverse events in patients receiving ICIs.
Authors
- Ken-ichi Sako (ORCID: https://orcid.org/0000-0003-1486-5825)
- Naohito Ide (ORCID: https://orcid.org/0000-0002-0292-3672)
- Yuki Tsuruta
- Tomoji Maeda
Institutions
- Nihon Pharmaceutical University (JP)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1080/14740338.2026.2618292
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00